Allen & Overy advises BNP Paribas on capital increase executed by AIXTRON
Allen & Overy has advised BNP Paribas in connection with a capital increase of around €100m (£85m) executed by AIXTRON.
The capital increase is to be effected through private placement by means of an accelerated bookbuilding process. AIXTRON will issue 10,223,133 new shares from the authorised capital to international institutional investors at a price of €9.90 per share. The offering represents almost 10 per cent of the registered share capital of AIXTRON prior to the transaction.
BNP Paribas and Deutsche Bank are acting as joint bookrunners for the transaction.
The Allen & Overy team comprised partners Dr Oliver Seiler (international capital markets) and Gernot Wagner (US corporate finance), as well as senior associates Dr Camilla Kehler-Weiß (international capital markets) and Dr Susanne Lenz (US corporate finance, all Frankfurt).
News from Allen & Overy
News from The Lawyer
Briefings from Allen & Overy
Money purchase deconstructed: working with the new definition — a checklist for trustees and administrators
The definition of money purchase benefits is changing, as are the rules on how schemes are required to deal with any benefit that becomes classified as a ‘non-money purchase’.
Despite the progress that has been made towards launching the European unitary patent system and the Unified Patent Court, Spain continues to actively oppose the changes.
Analysis from The Lawyer
At the time of its launch Accutrainee was described as a revolutionary change to the training model. Has it proved to be so? Not really.
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.